Frizzled homolog 10 (FZD10) has attracted attention as a promising therapeutic target for synovial sarcoma [33], as its expression is limited to the cell membrane of synovial sarcoma and absent from vital organs [34]. This evidence concerns the gene FZD10 and synovial sarcoma.